Treatment of relapsing polychondritis with rituximab: A retrospective study of nine patients

Arthritis Care and Research

Volumn 61, Issue 5, 2009, Pages 577-582

  Leroux, Gaëlle ^a   Costedoat Chalumeau, Nathalie ^a   Brihaye, Benoǐt ^a   Cohen Bittan, Judith ^a   Amoura, Zahir ^a   Haroche, Julien ^a   Limal, Nicolas ^a   Bletry, Olivie ^b   Piette, Jean Charles ^a  

^a SORBONNE UNIVERSITÉ   (France)

^b FOCH HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; C REACTIVE PROTEIN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DAPSONE; DOXORUBICIN; IMMUNOGLOBULIN; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RITUXIMAB; SALAZOSULFAPYRIDINE; STEROID; THALIDOMIDE; TUMOR NECROSIS FACTOR ALPHA; VINCRISTINE;

ADULT; AGED; ARTHRALGIA; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; B LYMPHOCYTE; CLINICAL ARTICLE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CORTICOSTEROID THERAPY; DISEASE ACTIVITY; DRUG EFFECT; FEMALE; FEVER; HUMAN; HUMAN TISSUE; HYPOTENSION; IMMUNOSUPPRESSIVE TREATMENT; JOINT RADIOGRAPHY; LEUKOENCEPHALOPATHY; LYMPHOCYTE COUNT; LYMPHOCYTE DEPLETION; MALE; MEDICAL RECORD REVIEW; PATHOPHYSIOLOGY; PROTEIN BLOOD LEVEL; RELAPSING POLYCHONDRITIS; REMISSION; RETROSPECTIVE STUDY; SPIROMETRY; TREATMENT DURATION; URTICARIA;

ADRENAL CORTEX HORMONES; ADULT; AGED; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LYMPHOCYTE DEPLETION; MALE; MIDDLE AGED; POLYCHONDRITIS, RELAPSING; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 66249118363     PISSN: 21514658     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.24366     Document Type: Article

References (26)

1. Pearson CM, Kline HM, Newcomer VD. Relapsing polychondritis. N Engl J Med 1960;263:51-8.
2. Michet CJ Jr, McKenna CH, Luthra HS, O'Fallon WM. Relapsing polychondritis: survival and predictive role of early disease manifestations. Ann Intern Med 1986;104:74-8.
3. Frances C, el Rassi R, Laporte JL, Rybojad M, Papo T, Piette JC. Dermatologic manifestations of relapsing polychondritis: a study of 200 cases at a single center. Medicine (Baltimore) 2001;80:173-9.
4. Bachor E, Blevins NH, Karmody C, Kuhnel T. Otologic manifestations of relapsing polychondritis: review of literature and report of nine cases. Auris Nasus Larynx 2006;33:135-41.
5. Isaak BL, Liesegang TJ, Michet CJ Jr. Ocular and systemic findings in relapsing polychondritis. Ophthalmology 1986;93: 681-9.
6. Piette JC, Papo T, Chavanon P, Huong DL, Frances C, Godeau P. Myelodysplasia and relapsing polychondritis [letter]. J Rheumatol 1995;22:1208-9.
7. Wright MJ, Bel'eed K, Sellars L, Richmond I. Relapsing polychondritis and myelodysplasia. Nephrol Dial Transplant 1997;12:1704-7.
8. Lichauco JJ, Lauer S, Shigemitsu HH, Bello JA, Bhattacharyya PK, Barland P, et al. Orbital mucosa-associated lymphoid tissue (MALT)-type lymphoma in a patient with relapsing polychondritis. Arthritis Rheum 2001;44:1713-5.
9. Diebold L, Rauh G, Jager K, Lohrs U. Bone marrow pathology in relapsing polychondritis: high frequency of myelodysplastic syndromes. Br J Haematol 1995;89:820-30.
10. Hebbar M, Brouillard M, Wattel E, Decoulx M, Hatron PY, Devulder B, et al. Association of myelodysplastic syndrome and relapsing polychondritis: further evidence. Leukemia 1995;9:731-3.
11. Hansson AS, Johannesson M, Svensson L, Nandakumar KS, Heinegard D, Holmdahl R. Relapsing polychondritis, induced in mice with matrilin 1, is an antibody- and complementdependent disease. Am J Pathol 2004;164:959-66.
12. Herrera I, Mannoni A, Altman RD. Relapsing polychondritis: commentary. Reumatismo 2002;54:301-6.
13. Goldenberg G, Sangueza OP, Jorizzo JL. Successful treatment of relapsing polychondritis with mycophenolate mofetil. J Dermatolog Treat 2006;17:158-9.
14. Saadoun D, Deslandre CJ, Allanore Y, Pham XV, Kahan A. Sustained response to infliximab in 2 patients with refractory relapsing polychondritis [letter]. J Rheumatol 2003;30: 1394-5.
15. Van der Lubbe PA, Miltenburg AM, Breedveld FC. Anti-CD4 monoclonal antibody for relapsing polychondritis. Lancet 1991;337:1349.
16. Rosen O, Thiel A, Massenkeil G, Hiepe F, Haupl T, Radtke H, et al. Autologous stem-cell transplantation in refractory autoimmune diseases after in vivo immunoablation and ex vivodepletion of mononuclear cells. Arthritis Res 2000;2:327-36.
17. Arkfeld DG. The potential utility of B cell-directed biologic therapy in autoimmune diseases. Rheumatol Int 2008;28:205- 15.
18. Damiani JM, Levine HL. Relapsing polychondritis: report of ten cases. Laryngoscope 1979;89:929-46.
19. Mohsenifar Z, Tashkin DP, Carson SA, Bellamy PE. Pulmonary function in patients with relapsing polychondritis. Chest 1982;81:711-7.
20. Gottenberg JE, Guillevin L, Lambotte O, Combe B, Allanore Y, Cantagrel A, et al. Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases. Ann Rheum Dis 2005;64:913-20.
21. Edwards JC, Szczepanski L, Szechinski J, Filipowicz- Sosnowska A, Emery P, Close DR, et al. Efficacy of B-celltargeted therapy with rituximab in patients with rheumatoid arthritis. N Engl J Med 2004;350:2572-81.
22. Keystone E, Fleischmann R, Emery P, Furst DE, van Vollenhoven R, Bathon J, et al. Safety and efficacy of additional courses of rituximab in patients with active rheumatoid arthritis: an open-label extension analysis. Arthritis Rheum 2007; 56:3896-908.
23. Looney RJ, Srinivasan R, Calabrese LH. The effects of rituximab on immunocompetency in patients with autoimmune disease [review]. Arthritis Rheum 2008;58:5-14.
24. Maloney DG, Grillo-Lopez AJ, White CA, Bodkin D, Schilder RJ, Neidhart JA, et al. IDEC-C2B8 (rituximab) anti-CD2 monoclonal antibody therapy in patients with relapsed lowgrade non-Hodgkin's lymphoma. Blood 1997;90:2188-95.
25. Foidart JM, Abe S, Martin GR, Zizic TM, Barnett EV, Lawley TJ, et al. Antibodies to type II collagen in relapsing polychondritis. N Engl J Med 1978;299:1203-7.
26. Hansson AS, Heinegard D, Piette JC, Burkhardt H, Holmdahl R. The occurrence of autoantibodies to matrilin 1 reflects a tissue-specific response to cartilage of the respiratory tract in patients with relapsing polychondritis. Arthritis Rheum 2001; 44:2402-12.